Try our beta test site
77 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Intervention: Drug: Oral Ibuprofen
22 Terminated
Has Results
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
Conditions: Patent Ductus Arteriosus;   Prematurity
Intervention: Drug: Ibuprofen
23 Completed Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
24 Completed Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Condition: Patent Ductus Arteriosus
Intervention:
25 Unknown  Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol;   Drug: Oral ibuprofen
26 Completed Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Continuous indomethacin;   Drug: ibuprofen
27 Withdrawn Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Condition: Patent Ductus Arteriosus
Intervention: Device: INVOS Cerebral/Somatic oximeter
28 Not yet recruiting Early Treatment Versus Expectative Management of PDA in Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Other: Expectative Management;   Drug: Indomethacin
29 Recruiting Paracetamol in Patent Ductus Arteriosus
Condition: Ductus Arteriosus, Patent
Interventions: Drug: Paracetamol;   Drug: Ibuprofen
30 Completed Patent Ductus Arteriosus (PDA) Screening Trial
Condition: Ductus Arteriosus, Patent
Interventions: Other: Nondisclosure of screening echocardiogram results;   Other: Disclosure of screening echocardiogram results
31 Withdrawn Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Ibuprofen
32 Completed Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
Condition: Ductus Arteriosus, Patent
Intervention:
33 Recruiting PDA Post NICU Discharge
Condition: Patent Ductus Arteriosus
Intervention:
34 Recruiting Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data
Condition: Ductus Arteriosus, Patent
Interventions: Device: TFU-NIRS;   Device: NIRS;   Device: EEG
35 Completed
Has Results
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Condition: Patent Ductus Arteriosus
Intervention: Device: PES first, then FFES
36 Active, not recruiting Paracetamol Treatment of the Borderline Significant PDA
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol drops;   Other: Placebo
37 Terminated Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
Condition: Patent Ductus Arteriosus
Interventions: Drug: optimized ibuprofen;   Drug: Standard Ibuprofen
38 Completed Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
Condition: Patent Ductus Arteriosus
Intervention: Drug: ibuprofen l-lysine iv solution (NeoProfen (R) )
39 Completed Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
Condition: Patent Ductus Arteriosus
Interventions: Other: feeding;   Other: fasting
40 Completed The Use of B-Type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
Conditions: Indomethacin Therapy;   Patent Ductus Arteriosus
Intervention: Procedure: Withhold standard INDO dose if BNP < 100 pg/ml

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.